Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:PRTK
Tag: NASDAQ:PRTK
PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
April 16, 2018
0
Here’s What’s Moving Conatus And Paratek
ME Staff
-
April 5, 2018
0
Analyst Activity – HC Wainwright Raises Its Price Target On Paratek...
ME Staff
-
March 2, 2018
0
PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
August 4, 2017
0
Paratek Pharmaceuticals Inc (NASDAQ:PRTK) Announces Successful Phase 3 trials For Omadacycline
Andy Parker
-
July 18, 2017
0
Analyst Activity – HC Wainwright Raises Its Price Target On Paratek...
ME Staff
-
July 18, 2017
0
PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
July 17, 2017
0
PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Entry into a Material...
ME Staff 8-k
-
June 29, 2017
0
PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
June 16, 2017
0
Here’s What’s Next For Paratek Pharmaceuticals Inc (NASDAQ:PRTK)
-
April 4, 2017
0
1
2
3
Page 2 of 3
